Skip to content
healthcare.dev

Terazosin Hydrochloride

NDC 71610-595, Terazosin Hydrochloride, capsule, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-595
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074823
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-595 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE5 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
71610-595-607161005956090 CAPSULE in 1 BOTTLE (71610-595-60)
71610-595-8071610059580180 CAPSULE in 1 BOTTLE (71610-595-80)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e5507ea6-bdb3-4363-a68b-0478cbb25f4a

Use it

Look up 71610-595 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-595 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-595. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.